Based on the Putnam Biorevolution ETF stock forecast from 0 analysts, the average analyst target price for Putnam Biorevolution ETF is not available over the next 12 months. Putnam Biorevolution ETF’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Putnam Biorevolution ETF is Neutral, which is based on 1 positive signals and 1 negative signals. At the last closing, Putnam Biorevolution ETF’s stock price was USD 31.62. Putnam Biorevolution ETF’s stock price has changed by -0.43% over the past week, -2.73% over the past month and +22.17% over the last year.
Analyst Ratings
Target Price Action
Rating Action
Analyst
Rating
Price
Date
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
What not to like
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Add to Watchlists
loading..
Download Confirmation
Premium customers can only download records visible on the current page view, while Platinum customers can download the first 1000 records.
Paid-only feature
CSV downloads are only available for paying customers.
Thank you for Sharing your Stock Targets for SYNB !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
